Market Cap (In CAD)
1.5 Million
Revenue (In CAD)
250.32 Thousand
Net Income (In CAD)
-300 Thousand
Avg. Volume
16.52 Thousand
- Currency
- CAD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.05-0.25
- PE
- -
- EPS
- -
- Beta Value
- 1.049
- ISIN
- CA29383X1033
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Timothy Ko
- Employee Count
- -
- Website
- https://www.entheonbiomedical.com
- Ipo Date
- 2018-05-03
- Details
- Entheon Biomedical Corp. operates as a biotechnology research and drug development company. It engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company serves physicians, clinics, and licensed psychiatrists in Canada, the United States, and European Union. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
More Stocks
-
NCRE
-
RAYALEMA
-
0860
-
3159
-
688398
-
UTTAMSUGARUttam Sugar Mills Limited
UTTAMSUGAR
-
ESLAW
-
QSI